Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus
The purpose of the first multidisciplinary Consensus: to comprehensively analyze the pathophysiological, clinical, and pharmacotherapeutic aspects of the syndrome of increased epithelial permeability (SPEP) as one of the basic mechanisms of the development of human pathology.The Consensus presents t...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2021-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849698992211886080 |
|---|---|
| author | V. I. Simanenkov I. V. Maev O. N. Tkacheva S. A. Alekseenko D. N. Andreev D. S. Bordin T. D. Vlasov N. M. Vorobyeva V. Grinevich I. V. Gubonina M. Yu. Drobizhev N. S. Efremov А. E. Karateev Yu. V. Kotovskaya Iu. A. Kravchuk G. G. Krivoborodov E. V. Kulchavenya A. M. Lila M. V. Mayevskaya E. A. Poluektova T. V. Popkova O. A. Sablin O. I. Solovyeva A. N. Suvorov G. N. Tarasova D. I. Trukhan A. V. Fedotova |
| author_facet | V. I. Simanenkov I. V. Maev O. N. Tkacheva S. A. Alekseenko D. N. Andreev D. S. Bordin T. D. Vlasov N. M. Vorobyeva V. Grinevich I. V. Gubonina M. Yu. Drobizhev N. S. Efremov А. E. Karateev Yu. V. Kotovskaya Iu. A. Kravchuk G. G. Krivoborodov E. V. Kulchavenya A. M. Lila M. V. Mayevskaya E. A. Poluektova T. V. Popkova O. A. Sablin O. I. Solovyeva A. N. Suvorov G. N. Tarasova D. I. Trukhan A. V. Fedotova |
| author_sort | V. I. Simanenkov |
| collection | DOAJ |
| description | The purpose of the first multidisciplinary Consensus: to comprehensively analyze the pathophysiological, clinical, and pharmacotherapeutic aspects of the syndrome of increased epithelial permeability (SPEP) as one of the basic mechanisms of the development of human pathology.The Consensus presents the structure of the three main levels of cytoprotection: preepithelial, epithelial and subepithelial, and the structure of intercellular tight contacts in epithelial tissues and endothelium is considered in detail. The clinical sections of the Consensus are devoted to the role of SPEP in diseases of the digestive system, cardio-cardio-vascular and other visceral systems. A separate section summarizes the materials illustrating the significant role of SPEP in mental disorders and diseases of the nervous system.A separate chapter of the Consensus is devoted to cytoprotective therapy in SPEP. Cytoprotective effects of such proton pump inhibitor as rabeprazole, bismuth preparations and probiotics have been shown. Special attention is paid to the clinical and pharmacological specialties of the cytoprotector of rebamipide. Clinical the effectiveness of re-bamipide shown as in functional, so in organic lesions of the digestive system. Its anti-cancer preventive effects are of practical importance. |
| format | Article |
| id | doaj-art-3a86c56b0a4741e0a4888f28e7a3fa52 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2021-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-3a86c56b0a4741e0a4888f28e7a3fa522025-08-20T03:18:45Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-02-0120110.15829/1728-8800-2021-27582221Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national ConsensusV. I. Simanenkov0I. V. Maev1O. N. Tkacheva2S. A. Alekseenko3D. N. Andreev4D. S. Bordin5T. D. Vlasov6N. M. Vorobyeva7V. Grinevich8I. V. Gubonina9M. Yu. Drobizhev10N. S. Efremov11А. E. Karateev12Yu. V. Kotovskaya13Iu. A. Kravchuk14G. G. Krivoborodov15E. V. Kulchavenya16A. M. Lila17M. V. Mayevskaya18E. A. Poluektova19T. V. Popkova20O. A. Sablin21O. I. Solovyeva22A. N. Suvorov23G. N. Tarasova24D. I. Trukhan25A. V. Fedotova26National Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMNational Medical Association for the Study of the Multimorbidity; Fund PROFMEDFORUMThe purpose of the first multidisciplinary Consensus: to comprehensively analyze the pathophysiological, clinical, and pharmacotherapeutic aspects of the syndrome of increased epithelial permeability (SPEP) as one of the basic mechanisms of the development of human pathology.The Consensus presents the structure of the three main levels of cytoprotection: preepithelial, epithelial and subepithelial, and the structure of intercellular tight contacts in epithelial tissues and endothelium is considered in detail. The clinical sections of the Consensus are devoted to the role of SPEP in diseases of the digestive system, cardio-cardio-vascular and other visceral systems. A separate section summarizes the materials illustrating the significant role of SPEP in mental disorders and diseases of the nervous system.A separate chapter of the Consensus is devoted to cytoprotective therapy in SPEP. Cytoprotective effects of such proton pump inhibitor as rabeprazole, bismuth preparations and probiotics have been shown. Special attention is paid to the clinical and pharmacological specialties of the cytoprotector of rebamipide. Clinical the effectiveness of re-bamipide shown as in functional, so in organic lesions of the digestive system. Its anti-cancer preventive effects are of practical importance.https://cardiovascular.elpub.ru/jour/article/view/2758epithelial permeabilitytight contactscytoprotective therapyrebamipide |
| spellingShingle | V. I. Simanenkov I. V. Maev O. N. Tkacheva S. A. Alekseenko D. N. Andreev D. S. Bordin T. D. Vlasov N. M. Vorobyeva V. Grinevich I. V. Gubonina M. Yu. Drobizhev N. S. Efremov А. E. Karateev Yu. V. Kotovskaya Iu. A. Kravchuk G. G. Krivoborodov E. V. Kulchavenya A. M. Lila M. V. Mayevskaya E. A. Poluektova T. V. Popkova O. A. Sablin O. I. Solovyeva A. N. Suvorov G. N. Tarasova D. I. Trukhan A. V. Fedotova Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus Кардиоваскулярная терапия и профилактика epithelial permeability tight contacts cytoprotective therapy rebamipide |
| title | Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus |
| title_full | Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus |
| title_fullStr | Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus |
| title_full_unstemmed | Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus |
| title_short | Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus |
| title_sort | syndrome of increased epithelial permeability in clinical practice multidisciplinary national consensus |
| topic | epithelial permeability tight contacts cytoprotective therapy rebamipide |
| url | https://cardiovascular.elpub.ru/jour/article/view/2758 |
| work_keys_str_mv | AT visimanenkov syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT ivmaev syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT ontkacheva syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT saalekseenko syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT dnandreev syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT dsbordin syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT tdvlasov syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT nmvorobyeva syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT vgrinevich syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT ivgubonina syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT myudrobizhev syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT nsefremov syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT aekarateev syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT yuvkotovskaya syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT iuakravchuk syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT ggkrivoborodov syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT evkulchavenya syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT amlila syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT mvmayevskaya syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT eapoluektova syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT tvpopkova syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT oasablin syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT oisolovyeva syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT ansuvorov syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT gntarasova syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT ditrukhan syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus AT avfedotova syndromeofincreasedepithelialpermeabilityinclinicalpracticemultidisciplinarynationalconsensus |